| S2567 |
MPA (Medroxyprogesterone acetate)
|
Medroxyprogesterone acetate (MPA) is a synthetic progestin that acts as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding.
|
-
Cancer Sci, 2025, 10.1111/cas.70081
-
Cell Prolif, 2024, e13780.
-
J Transl Med, 2024, 22(1):478
|
|
| S1705 |
Progesterone
|
Progesterone is an endogenous steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis of humans and other species. This compound is a potent agonist of the nuclear progesterone receptor (nPR) with Kd of 1 nM; an agonist of the membrane progesterone receptors(mPRs); an antagonist of the σ1 receptor.
|
-
Bone Res, 2025, 13(1):37
-
Nat Commun, 2024, 15(1):8708
-
Dev Cell, 2024, S1534-5807(24)00326-5
|
|
| S3167 |
Altrenogest
|
Altrenogest (A35957, RU2267,R2267) is a progestogen structurally related to veterinary steroid trenbolone.
|
|
|
| S4638 |
Desogestrel
|
Desogestrel (Cerazette, Desogen, Desogestrelum, Org-2969) is a synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.
|
|
|
| S4883 |
Lynestrenol
|
Lynestrenol (Ethinylestrenol) is a synthetic progestational hormone, an agonist of the progesterone receptor and has weak androgenic and estrogenic activity.
|
|
|
| S3635 |
Medroxyprogesterone
|
Medroxyprogesterone (MP) is a synthetic pregnane steroid and a derivative of progesterone. It is a potent progesterone receptor agonist.
|
|
|
| S4097 |
Dydrogesterone
|
Dydrogesterone (NSC 92336) is an orally active progestogen which acts directly on the uterus, producing a complete secretory endometrium in an estrogen-primed uterus.
|
|
|
| S4507 |
17-Hydroxyprogesterone
|
17-Hydroxyprogesterone (17-OHP) is an endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones, including the corticosteroids and the androgens and the estrogens.
|
|
|
| E2664 |
Cridanimod
|
Cridanimod, a low-Mw interferon-inducer (IFN-inducer), recognizes the intracellular signaling protein stimulator of interferon genes (STING), resulting in the STING-TBK1-IRF3 pathway activation and synthesis of type I IFNs (subtypes IFN-α and IFN-β).
|
|
|